Get the Stockscreener App
20.36
2.14%
-0.445
Claritev Corp stock is traded at $20.36, with a volume of 48,202.
It is down -2.14% in the last 24 hours and down -36.31% over the past month.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
See More
Previous Close:
$20.80
Open:
$20.93
24h Volume:
48,202
Relative Volume:
0.21
Market Cap:
$334.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-20.80%
1M Performance:
-36.31%
6M Performance:
-69.02%
1Y Performance:
+0.00%
1-Day Range:
$19.93
$21.05
1-Week Range:
$19.93
$27.16
52-Week Range:
$16.38
$74.07
Claritev Corp Stock (CTEV) Company Profile
Name
Claritev Corp
Sector
Industry
Phone
212-780-2000
Address
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
20.27 | 343.73M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
170.83 | 29.10B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
50.38 | 9.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
37.87 | 7.22B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
74.00 | 6.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
24.72 | 4.80B | 550.17M | 201.35M | 232.07M | 1.00 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Initiated | Guggenheim | Buy |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Oct-21-25 | Upgrade | Citigroup | Neutral → Buy |
| May-29-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Neutral |
| Dec-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Jul-12-22 | Initiated | Goldman | Neutral |
| Oct-04-21 | Resumed | Citigroup | Buy |
| Apr-07-21 | Initiated | B. Riley Securities | Buy |
| Mar-19-21 | Initiated | Barclays | Equal Weight |
View All
Claritev Corp Stock (CTEV) Latest News
Claritev’s Strategic Pivot: A Critical Juncture for the Former MultiPlan - AD HOC NEWS
What Catalysts Are Shifting The Claritev (CTEV) Narrative Now - Yahoo Finance
RSI Check: Can Claritev Corporation weather a recessionQuarterly Profit Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Ideas Watch: Is Claritev Corporation part of any ETFChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
Swing Trade: What is the earnings history of Claritev Corporation2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
IPO Launch: What are analysts price targets for Claritev CorporationWeekly Loss Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Aug Weekly: What is the next catalyst for Claritev Corporation2025 Top Decliners & Comprehensive Market Scan Insights - baoquankhu1.vn
CTEVClaritev Corp Latest Stock News & Market Updates - Stock Titan
Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call - Business Wire
AustralianSuper Pty Ltd Buys Shares of 3,195,270 Claritev $CTEV - MarketBeat
Analyst Calls: Will Claritev Corporation benefit from seasonalityWeekly Stock Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Claritev partners with Kinetiq Health to tackle high-cost healthcare claims - Investing.com Australia
Claritev (CTEV) Enters Strategic Partnership with Kinetiq Health - GuruFocus
Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty - marketscreener.com
Claritev : and Kinetiq Health enter into strategic agreement to strengthen cost management and advance claims surveillance and diagnostic certainty - marketscreener.com
Claritev Corporation (NYSE:CTEV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st
Claritev Corporation (CTEV) Stock Analysis: A Closer Look At The 90.45% Potential Upside - DirectorsTalk Interviews
Lobbying Update: $150,000 of CLARITEV (FORMERLY MULTIPLAN CORPORATION) lobbying was just disclosed - Quiver Quantitative
CTEV: Transformation, tech investment, and client focus drive growth and innovation in healthcare - TradingView
Claritev outlines long-term growth strategy at healthcare conference - TipRanks
Claritev Corp Releases Investor Presentation at Healthcare Conference - TradingView
Claritev: The Middleman In A Vertically Integrated Market (NYSE:CTEV) - Seeking Alpha
Claritev (CTEV) Price Target Decreased by 26.64% to 66.10 - Nasdaq
Aug Volume: What is Claritev Corporations P E ratio telling us2025 Macro Impact & Verified Short-Term Trading Plans - baoquankhu1.vn
Chipmakers Recap: How Claritev Corporation stock reacts to bond yieldsJuly 2025 Macro Moves & Consistent Return Investment Signals - Bộ Nội Vụ
Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target - marketscreener.com
Guggenheim initiates coverage on Claritev stock with Buy rating By Investing.com - Investing.com UK
Guggenheim initiates coverage on Claritev stock with Buy rating - Investing.com
175,767 Options of Claritev Corporation are subject to a Lock-Up Agreement Ending on 12-JAN-2026. - marketscreener.com
Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates - MSN
Claritev announces pricing of 1.5 million share secondary offering at $51.50 a piece - MSN
Why Claritev Corporation stock could rally in 20252025 Volatility Report & Daily Stock Trend Reports - Улправда
Does Claritev Corporation stock trade at a discount to peersTrend Reversal & AI Forecasted Entry/Exit Points - Улправда
Wells Fargo Initiates Coverage of Claritev (CTEV) with Equal-Weight Recommendation - Nasdaq
Claritev (CTEV): Citigroup Lowers Price Target while Maintaining Buy Rating | CTEV Stock News - GuruFocus
Wells Fargo initiates Claritev stock with Equal Weight rating, $33 target - Investing.com Nigeria
Wells Fargo Initiates Coverage on CTEV with Equal-Weight Rating - GuruFocus
Wells Fargo initiates Claritev stock with Equal Weight rating, $33 target By Investing.com - Investing.com South Africa
Claritev price target lowered to $63 from $80 at Citi - TipRanks
What Catalysts Are Reshaping The Claritev (CTEV) Narrative On Growth Versus Leverage Risks - Yahoo Finance
Claritev Corporation Class A Common Stock (NY: CTEV - FinancialContent
Why Claritev Corporation Class stock stays resilientMarket Activity Summary & Reliable Price Breakout Alerts - ulpravda.ru
Can Claritev Corporation stock withstand economic slowdownJuly 2025 PostEarnings & Stepwise Trade Signal Guides - ulpravda.ru
Claritev initiated with an Equal Weight at Wells Fargo - TipRanks
Why Claritev Corporation stock remains a top recommendationJuly 2025 Analyst Calls & Weekly High Conviction Ideas - Улправда
Sentiment Review: Does Claritev Corporation stock trade at a discount to peersIPO Watch & Fast Entry High Yield Tips - Улправда
Can Claritev Corporation stock weather global recessionJuly 2025 Trade Ideas & Growth Oriented Trading Recommendations - Улправда
Star TribuneClaritev Corporation Class A Common Stock (NYSE:CTEV) Stock Quote - FinancialContent
Claritev Corporation to Present at J.P. Morgan Healthcare Conference - 01net
Claritev Corp Stock (CTEV) Financials Data
There is no financial data for Claritev Corp (CTEV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
9.65%
4.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):